{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:14:05Z","timestamp":1790460845470,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T00:00:00Z","timestamp":1527292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1205-6","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T07:10:44Z","timestamp":1527318644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Serum amyloid A primes microglia for ATP-dependent interleukin-1\u03b2 release"],"prefix":"10.1186","volume":"15","author":[{"given":"Laura","family":"Facci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Barbierato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"Zusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5012-9660","authenticated-orcid":false,"given":"Stephen D.","family":"Skaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,26]]},"reference":[{"key":"1205_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448\u201354.","journal-title":"N Engl J Med"},{"key":"1205_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","volume":"6","author":"E Gruys","year":"2005","unstructured":"Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6:1045\u201356.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1205_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","volume":"583","author":"L Sun","year":"2016","unstructured":"Sun L, Ye RD. Serum amyloid A1: structure, function and gene polymorphism. Gene. 2016;583:48\u201357.","journal-title":"Gene"},{"key":"1205_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1046\/j.1365-3083.1997.d01-128.x","volume":"46","author":"Y Kumon","year":"1997","unstructured":"Kumon Y, Sipe JD, Brinckerhoff CE, Schreiber BM. Regulation of extrahepatic apolipoprotein serum amyloid A (ApoSAA) gene expression by interleukin-1 alpha alone: synthesis and secretion of ApoSAA by cultured aortic smooth muscle cells. Scand J Immunol. 1997;46:284\u201391.","journal-title":"Scand J Immunol"},{"key":"1205_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2015.12.007","volume":"292","author":"I Rajkovic","year":"2016","unstructured":"Rajkovic I, Denes A, Allan SM, Pinteaux E. Emerging roles of the acute phase protein pentraxin-3 during central nervous system disorders. J Neuroimmunol. 2016;292:27\u201333.","journal-title":"J Neuroimmunol"},{"key":"1205_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0005-2760(96)00143-9","volume":"1344","author":"I Hardard\u00f3ttir","year":"1997","unstructured":"Hardard\u00f3ttir I, Sipe J, Moser AH, Fielding CJ, Feingold KR, Gr\u00fcnfeld C. LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim Biophys Acta. 1997;1344:210\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"1205_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0304-3940(97)00196-1","volume":"225","author":"JS Liang","year":"1997","unstructured":"Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer\u2019s disease brain. Neurosci Lett. 1997;225:73\u20136.","journal-title":"Neurosci Lett"},{"key":"1205_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbalip.2006.03.013","volume":"1761","author":"T Miida","year":"2006","unstructured":"Miida T, Yamada T, Seino U, Ito M, Fueki Y, Takahashi A, Kosuge K, Soda S, Hanyu O, Obayashi K, Miyazaki O, Okada M. Serum amyloid A (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta. 2006;1761:424\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"1205_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JAD-1999-1303","volume":"1","author":"MS Kindy","year":"1999","unstructured":"Kindy MS, Yu J, Guo JT, Zhu H. Apolipoprotein serum amyloid A in Alzheimer\u2019s disease. J Alzheimers Dis. 1999;1:155\u201367.","journal-title":"J Alzheimers Dis"},{"key":"1205_CR10","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1523\/JNEUROSCI.22-14-05900.2002","volume":"22","author":"JT Guo","year":"2002","unstructured":"Guo JT, Yu J, Grass D, de Beer FC, Kindy MS. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci. 2002;22:5900\u20139.","journal-title":"J Neurosci"},{"key":"1205_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/13506120009146246","volume":"7","author":"TF Chung","year":"2000","unstructured":"Chung TF, Sipe JD, McKee A, Fine RE, Schreiber BM, Liang JS, Johnson RJ. Serum amyloid A in Alzheimer\u2019s disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid. 2000;7:105\u201310.","journal-title":"Amyloid"},{"key":"1205_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12529-7","volume":"7","author":"M Barbierato","year":"2017","unstructured":"Barbierato M, Borri M, Facci L, Zusso M, Skaper SD, Giusti P. Expression and differential responsiveness of central nervous system glial cell populations to the acute phase protein serum amyloid A. Sci Rep. 2017;7:1. https:\/\/doi.org\/10.1038\/s41598-017-12529-7 .","journal-title":"Sci Rep"},{"key":"1205_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jnr.20266","volume":"78","author":"A Basu","year":"2004","unstructured":"Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res. 2004;78:151\u20136.","journal-title":"J Neurosci Res"},{"key":"1205_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2017.00123","volume":"8","author":"AL Giuliani","year":"2017","unstructured":"Giuliani AL, Sarti AC, Falzoni S, Di Virgilio F. The P2X7 receptor-interleukin-1 liaison. Front Pharmacol. 2017;8:123. https:\/\/doi.org\/10.3389\/fphar.2017.00123 .","journal-title":"Front Pharmacol"},{"key":"1205_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nri1664","volume":"5","author":"SM Allan","year":"2005","unstructured":"Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5:629\u201340.","journal-title":"Nat Rev Immunol"},{"key":"1205_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633\u201352.","journal-title":"Nat Rev Drug Discov"},{"key":"1205_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1742-2094-10-143","volume":"10","author":"S Tanaka","year":"2013","unstructured":"Tanaka S, Ishii A, Ohtaki H, Shioda S, Yoshida T, Numazawa S. Activation of microglia induces symptoms of Parkinson\u2019s disease in wild-type, but not in IL-1 knockout mice. J Neuroinflammation. 2013;10:143. https:\/\/doi.org\/10.1186\/1742-2094-10-143 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.0953-816x.2001.01686.x","volume":"14","author":"N Chauvet","year":"2001","unstructured":"Chauvet N, Palin K, Verrier D, Poole S, Dantzer R, Lestage J. Rat microglial cells secrete predominantly the precursor of interleukin-1\u03b2 in response to lipopolysaccharide. Eur J Neurosci. 2001;14:609\u201317.","journal-title":"Eur J Neurosci"},{"key":"1205_CR19","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1096\/fj.14-268714","volume":"29","author":"A Franceschini","year":"2015","unstructured":"Franceschini A, Capece M, Chiozzi P, Falzoni S, Sanz JM, Sarti AC, Bonora M, Pinton P, Di Virgilio F. The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J. 2015;29:2450\u201361.","journal-title":"FASEB J"},{"key":"1205_CR20","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","volume":"176","author":"D Ferrari","year":"2006","unstructured":"Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol. 2006;176:3877\u201383.","journal-title":"J Immunol"},{"key":"1205_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Eltzschig HK. Nucleotide signalling during inflammation. Nature. 2014;509:310\u20137.","journal-title":"Nature"},{"key":"1205_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fimmu.2015.00422","volume":"6","author":"E Venereau","year":"2015","unstructured":"Venereau E, Ceriotti C, Bianchi ME. DAMPs from cell death to new life. Front Immunol. 2015;6:422. https:\/\/doi.org\/10.3389\/fimmu.2015.00422 .","journal-title":"Front Immunol"},{"key":"1205_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/187152712803581137","volume":"11","author":"C Volont\u00e9","year":"2012","unstructured":"Volont\u00e9 C, Apolloni S, Skaper SD, Burnstock G. P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets. 2012;11:705\u201321.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1205_CR24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1189\/jlb.0407203","volume":"83","author":"S Sandri","year":"2008","unstructured":"Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A. Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol. 2008;83:1174\u201380.","journal-title":"J Leukoc Biol"},{"key":"1205_CR25","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","volume":"186","author":"K Niemi","year":"2011","unstructured":"Niemi K, Teiril\u00e4 L, Lappalainen J, Rajam\u00e4ki K, Baumann MH, \u00d6\u00f6rni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol. 2011;186:6119\u201328.","journal-title":"J Immunol"},{"key":"1205_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vetimm.2013.06.010","volume":"155","author":"T Tamamoto","year":"2013","unstructured":"Tamamoto T, Ohno K, Goto-Koshino Y, Tsujimoto H. Feline serum amyloid A protein as an endogenous toll-like receptor 4 agonist. Vet Immunol Immunopathol. 2013;155:190\u20136.","journal-title":"Vet Immunol Immunopathol"},{"key":"1205_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.scr.2015.06.008","volume":"15","author":"R Ebert","year":"2015","unstructured":"Ebert R, Benisch P, Krug M, Zeck S, Mei\u00dfner-Weigl J, Steinert A, Rauner M, Hofbauer L, Jakob F. Acute phase serum amyloid A induces proinflammatory cytokines and mineralization via toll-like receptor 4 in mesenchymal stem cells. Stem Cell Res. 2015;15:231\u20139.","journal-title":"Stem Cell Res"},{"key":"1205_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4049\/jimmunol.181.1.22","volume":"181","author":"N Cheng","year":"2008","unstructured":"Cheng N, He R, Tian J, Ye PP, Ye RD. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol. 2008;181:22\u20136.","journal-title":"J Immunol"},{"key":"1205_CR29","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1136\/annrheumdis-2015-207655","volume":"75","author":"M Connolly","year":"2016","unstructured":"Connolly M, Rooney PR, McGarry T, Maratha AX, McCormick J, Miggin SM, Veale DJ, Fearon U. Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms. Ann Rheum Dis. 2016;75:1392\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1205_CR30","doi-asserted-by":"publisher","first-page":"7150509","DOI":"10.1155\/2016\/7150509","volume":"2016","author":"E Nishida","year":"2016","unstructured":"Nishida E, Aino M, Kobayashi SI, Okada K, Ohno T, Kikuchi T, Hayashi JI, Yamamoto G, Hasegawa Y, Mitani A. Serum amyloid A promotes E-selectin expression via toll-like receptor 2 in human aortic endothelial cells. Mediat Inflamm. 2016;2016:7150509. https:\/\/doi.org\/10.1155\/2016\/7150509 .","journal-title":"Mediat Inflamm"},{"key":"1205_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0146882","volume":"11","author":"SL Passey","year":"2016","unstructured":"Passey SL, Bozinovski S, Vlahos R, Anderson GP, Hansen MJ. Serum amyloid A induces toll-like receptor 2-dependent inflammatory cytokine expression and atrophy in C2C12 skeletal muscle myotubes. PLoS One. 2016;11:1. https:\/\/doi.org\/10.1371\/journal.pone.0146882.","journal-title":"PLoS One"},{"key":"1205_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnins.2015.00148","volume":"9","author":"RJ Rodrigues","year":"2015","unstructured":"Rodrigues RJ, Tom\u00e9 AR, Cunha RA. ATP as a multi-target danger signal in the brain. Front Neurosci. 2015;9:148. https:\/\/doi.org\/10.3389\/fnins.2015.00148 .","journal-title":"Front Neurosci"},{"key":"1205_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","volume":"35","author":"B Sperl\u00e1gh","year":"2014","unstructured":"Sperl\u00e1gh B, Illes P. P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci. 2014;35:537\u201347.","journal-title":"Trends Pharmacol Sci"},{"key":"1205_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4939-7571-6_4","volume":"1727","author":"SD Skaper","year":"2018","unstructured":"Skaper SD, Facci L. Culture of neonatal rodent microglia, astrocytes, and oligodendrocytes from the cortex, spinal cord, and cerebellum. Methods Mol Biol. 2018;1727:49\u201361.","journal-title":"Methods Mol Biol"},{"key":"1205_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12974-015-0458-6","volume":"12","author":"C Marinelli","year":"2015","unstructured":"Marinelli C, Di Liddo R, Facci L, Bertalot T, Conconi MT, Zusso M, Skaper SD, Giusti P. Ligand engagement of toll-like receptors regulates their expression in cortical microglia and astrocytes. J Neuroinflammation. 2015;12:244. https:\/\/doi.org\/10.1186\/s12974-015-0458-6 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jneumeth.2005.06.016","volume":"150","author":"ME Hamby","year":"2006","unstructured":"Hamby ME, Uliasz TF, Hewett SJ, Hewett JA. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods. 2006;150:128\u201337.","journal-title":"J Neurosci Methods"},{"key":"1205_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/18715273113129990064","volume":"12","author":"M Barbierato","year":"2013","unstructured":"Barbierato M, Facci L, Argentini C, Marinelli C, Skaper SD, Giusti P. Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype. CNS Neurol Disord Drug Targets. 2013;12:608\u201318.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1205_CR38","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1038\/srep06824","volume":"4","author":"L Facci","year":"2014","unstructured":"Facci L, Barbierato M, Marinelli C, Argentini C, Skaper SD, Giusti P. Toll-like receptors 2, -3 and -4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1\u03b2 release. Sci Rep. 2014;4:6824. https:\/\/doi.org\/10.1038\/srep06824.","journal-title":"Sci Rep"},{"key":"1205_CR39","doi-asserted-by":"publisher","first-page":"23658","DOI":"10.1074\/jbc.M513646200","volume":"281","author":"AA Culbert","year":"2006","unstructured":"Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M, Richardson JC. MAPKAP kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: relevance to neuroinflammation in a transgenic mouse model of Alzheimer\u2019s disease. J Biol Chem. 2006;281:23658\u201367.","journal-title":"J Biol Chem"},{"key":"1205_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/glia.20379","volume":"54","author":"SD Skaper","year":"2006","unstructured":"Skaper SD, Facci L, Culbert AA, Evans NA, Chessell I, Davis JB, Richardson JC. P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia. 2006;54:234\u201342.","journal-title":"Glia"},{"key":"1205_CR41","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.4049\/jimmunol.164.9.4893","volume":"164","author":"M Sanz","year":"2000","unstructured":"Sanz M, Di Virgilio F. Kinetics and mechanism of ATP-dependent IL-1\u03b2 release from microglial cells. J Immunol. 2000;164:4893\u20138.","journal-title":"J Immunol"},{"key":"1205_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4939-7571-6_13","volume":"1727","author":"L Facci","year":"2018","unstructured":"Facci L, Skaper SD. Cell enumeration assays: application of the MTT and sulforhodamine B assays to lipopolysaccharide-stimulated neonatal rodent microglia. Methods Mol Biol. 2018;1727:167\u201378.","journal-title":"Methods Mol Biol"},{"key":"1205_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/JAD-130818","volume":"38","author":"Y Yu","year":"2014","unstructured":"Yu Y, Liu J, Li SQ, Peng L, Ye RD. Serum amyloid a differentially activates microglia and astrocytes via the PI3K pathway. J Alzheimers Dis. 2014;38:133\u201344.","journal-title":"J Alzheimers Dis"},{"key":"1205_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/glia.22296","volume":"60","author":"TH Holm","year":"2012","unstructured":"Holm TH, Draeby D, Owens T. Microglia are required for astroglial toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia. 2012;60:630\u20138.","journal-title":"Glia"},{"key":"1205_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cytogfr.2015.12.010","volume":"30","author":"M De Buck","year":"2016","unstructured":"De Buck M, Gouwy M, Wang JM, Van Snick J, Proost P, Struyf S, Van Damme J. The cytokine-serum amyloid A-chemokine network. Cytokine Growth Factor Rev. 2016;30:55\u201369.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1205_CR46","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/0306-4522(94)00549-K","volume":"65","author":"AM Van Dam","year":"1995","unstructured":"Van Dam AM, Bauer J, Tilders FJ, Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience. 1995;65:815\u201326.","journal-title":"Neuroscience"},{"key":"1205_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","volume":"179","author":"M Casula","year":"2011","unstructured":"Casula M, Iyer AM, Spliet WG, Anink JJ, Steentjes K, Sta M, Troost D, Aronica E. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience. 2011;179:233\u201343.","journal-title":"Neuroscience"},{"key":"1205_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-2094-10-23","volume":"10","author":"L Yao","year":"2013","unstructured":"Yao L, Kan EM, Lu J, Hao A, Dheen ST, Kaur C, Ling EA. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflammation. 2013;10:23. https:\/\/doi.org\/10.1186\/1742-2094-10-23 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-11-15","volume":"11","author":"Y Wang","year":"2014","unstructured":"Wang Y, Ge P, Yang L, Wu C, Zha H, Luo T, Y Z. Protection of ischemic post conditioning against transient focal ischemia-induced brain damage is associated with inhibition of neuroinflammation via modulation of TLR2 and TLR4 pathways. J Neuroinflammation. 2014;11:15. https:\/\/doi.org\/10.1186\/1742-2094-11-15 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1742-2094-11-62","volume":"11","author":"XQ Li","year":"2014","unstructured":"Li XQ, Lv HW, Tan WF, Fang B, Wang H, Ma H. Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia\/reperfusion injury in rats. J Neuroinflammation. 2014;11:62. https:\/\/doi.org\/10.1186\/1742-2094-11-62 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR51","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1074\/jbc.M607277200","volume":"282","author":"D Kim","year":"2007","unstructured":"Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, Na HS, Oh SB, Lee SJ. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem. 2007;282:14975\u201383.","journal-title":"J Biol Chem"},{"key":"1205_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-4-26","volume":"4","author":"J Saura","year":"2007","unstructured":"Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation. 2007;4:26. https:\/\/doi.org\/10.1186\/1742-2094-4-26 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR53","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1046\/j.1460-9568.2002.02199.x","volume":"16","author":"C Sol\u00e0","year":"2002","unstructured":"Sol\u00e0 C, Casal C, Tusell JM, Serratosa J. Astrocytes enhance lipopolysaccharide-induced nitric oxide production by microglial cells. Eur J Neurosci. 2002;16:1275\u201383.","journal-title":"Eur J Neurosci"},{"key":"1205_CR54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/glia.20689","volume":"56","author":"SJ Crocker","year":"2008","unstructured":"Crocker SJ, Frausto RF, Whitton JL, Milner R. A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia. 2008;56:1187\u201398.","journal-title":"Glia"},{"key":"1205_CR55","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.4049\/jimmunol.131.5.2282","volume":"131","author":"DL Thiele","year":"1983","unstructured":"Thiele DL, Kurosaka M, Lipsky PE. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, l-leucine methyl ester. J Immunol. 1983;131:2282\u201390.","journal-title":"J Immunol"},{"key":"1205_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/(SICI)1097-4547(19970901)49:5<576::AID-JNR8>3.0.CO;2-8","volume":"49","author":"G Guillemin","year":"1997","unstructured":"Guillemin G, Boussin FD, Croitoru J, Franck-Duchenne M, Le Grand R, Lazarini F, Dormont D. Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains. J Neurosci Res. 1997;49:576\u201391.","journal-title":"J Neurosci Res"},{"key":"1205_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0165-5728(98)00240-9","volume":"94","author":"SJ Hewett","year":"1999","unstructured":"Hewett SJ. Interferon-gamma reduces cyclooxygenase-2-mediated prostaglandin E2 production from primary mouse astrocytes independent of nitric oxide formation. J Neuroimmunol. 1999;94:134\u201343.","journal-title":"J Neuroimmunol"},{"key":"1205_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1471-4159.2010.07084.x","volume":"116","author":"S Kim","year":"2011","unstructured":"Kim S, Steelman AJ, Koito H, Li J. Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. J Neurochem. 2011;116:53\u201366.","journal-title":"J Neurochem"},{"key":"1205_CR59","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1124\/jpet.106.111559","volume":"319","author":"P Honore","year":"2006","unstructured":"Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther. 2006;319:1376\u201385.","journal-title":"J Pharmacol Exp Ther"},{"key":"1205_CR60","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/mol.105.019695","volume":"69","author":"M Li","year":"2006","unstructured":"Li M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4- fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signalling. Mol Pharmacol. 2006;69:1288\u201395.","journal-title":"Mol Pharmacol"},{"key":"1205_CR61","doi-asserted-by":"publisher","first-page":"12246","DOI":"10.1002\/anie.201204910","volume":"51","author":"K Chang","year":"2013","unstructured":"Chang K, Wang X, Zhang S, Yin H. Discovery of small molecule inhibitors of the TLR1-TLR2 complex. Angew Chem Int Ed Engl. 2013;51:12246\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1205_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","volume":"584","author":"T Kawamoto","year":"2008","unstructured":"Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. TAK-242 selectively suppresses toll-like receptor 4-signalling mediated by the intracellular domain. Eur J Pharmacol. 2008;584:40\u20138.","journal-title":"Eur J Pharmacol"},{"key":"1205_CR63","first-page":"317","volume-title":"Inflammation: basic principles and clinical correlates","author":"I Kushner","year":"1999","unstructured":"Kushner I, Rzewnicki D. Acute phase response. In: JGallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Willams & Wilkins; 1999. p. 317\u201329."},{"key":"1205_CR64","doi-asserted-by":"crossref","unstructured":"Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immunol. 2007;8:11\u20133.","DOI":"10.1038\/ni0107-11"},{"key":"1205_CR65","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri1372","volume":"4","author":"SY Seong","year":"2004","unstructured":"Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004;4:469\u201378.","journal-title":"Nat Rev Immunol"},{"key":"1205_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-5728(98)00037-X","volume":"88","author":"G Ristori","year":"1998","unstructured":"Ristori G, Laurenti F, Stacchini P, Gasperini C, Buttinelli C, Pozzilli C, Salvetti M. Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis. J Neuroimmunol. 1998;88:9\u201312.","journal-title":"J Neuroimmunol"},{"key":"1205_CR67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.03.004","volume":"259","author":"H Yokote","year":"2013","unstructured":"Yokote H, Yagi Y, Watanabe Y, Amino T, Kamata T, Mizusawa H. Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI. J Neuroimmunol. 2013;259:92\u20135.","journal-title":"J Neuroimmunol"},{"key":"1205_CR68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1096\/fj.09-138883","volume":"24","author":"SD Skaper","year":"2010","unstructured":"Skaper SD, Debetto P, Giusti P. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J. 2010;24:337\u201345.","journal-title":"FASEB J"},{"key":"1205_CR69","doi-asserted-by":"publisher","first-page":"13309","DOI":"10.1074\/jbc.M209478200","volume":"278","author":"LK Parvathenani","year":"2003","unstructured":"Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer\u2019s disease. J Biol Chem. 2003;278:13309\u201317.","journal-title":"J Biol Chem"},{"key":"1205_CR70","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405.","journal-title":"Lancet Neurol"},{"key":"1205_CR71","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1074\/jbc.M114.635763","volume":"290","author":"YR Ji","year":"2015","unstructured":"Ji YR, Kim HJ, Bae KB, Lee S, Kim MO, Ryoo ZY. Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via toll-like receptor 2 in mice. J Biol Chem. 2015;290:12804\u201311.","journal-title":"J Biol Chem"},{"key":"1205_CR72","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1073\/pnas.1006496107","volume":"107","author":"JA Sloane","year":"2010","unstructured":"Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A. 2010;107:11555\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1205_CR73","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","volume":"265","author":"CM Uhlar","year":"1999","unstructured":"Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501\u201323.","journal-title":"Eur J Biochem"},{"key":"1205_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG. TNF signalling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation. 2008;5:45. https:\/\/doi.org\/10.1186\/1742-2094-5-45 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR75","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI115102","volume":"87","author":"K Selmaj","year":"1991","unstructured":"Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest. 1991;87:949\u201354.","journal-title":"J Clin Invest"},{"key":"1205_CR76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/clim.1998.4653","volume":"90","author":"RA Dal Canto","year":"1999","unstructured":"Dal Canto RA, Shaw MK, Nolan GP, Steinman L, Fathman CG. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. Clin Immunol. 1999;90:10\u20134.","journal-title":"Clin Immunol"},{"key":"1205_CR77","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1073\/pnas.92.24.11294","volume":"92","author":"L Probert","year":"1995","unstructured":"Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 1995;92:11294\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1205_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1742-2094-5-33","volume":"5","author":"AJ Sharp","year":"2008","unstructured":"Sharp AJ, Polak PE, Simonini V, Lin SX, Richardson JC, Bongarzone ER, Feinstein DL. P2X7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2008;5:33. https:\/\/doi.org\/10.1186\/1742-2094-5-33 .","journal-title":"J Neuroinflammation"},{"key":"1205_CR79","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/imm.12163","volume":"141","author":"L Peferoen","year":"2014","unstructured":"Peferoen L, Kipp M, van der Valk P, van Noort JM. Amor S. Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology. 2014;141:302\u201313.","journal-title":"Immunology"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1205-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T20:50:58Z","timestamp":1693687858000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1205-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,26]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1205-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,26]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were conducted in compliance with Italian Ministry of Health (art. 31, D.L. 26\/2014) guidelines for the care and use of laboratory animals, and were approved by the Institutional Animal Care and Use Committee of the University of Padua (958\/2016-PR).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"164"}}